Sanofi-Aventis rumoured to buy Brazilian generics giant
This article was originally published in Scrip
Executive Summary
A report in the Brazilian newspaper Valor has sparked rumours that Sanofi-Aventis is looking to buy Medley, Brazil's biggest generics company.